// App-Quantinova.ai

TCT-228 : Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study

Researchers

Presenter

  • Mauro Chiarito

Principal Investigators

  • Carlo Andrea Pivato

  • Davide Cao

  • Zhongjie Zhang

  • Samantha Sartori

  • Johny Nicolas

  • Matteo Nardin

  • Samir Kapadia

  • Sandra Weiss

  • Sunil Rao

  • Timothy Henry

  • Mark Effron

  • William Weintraub

  • Stuart Pocock

  • George Dangas

  • Annapoorna Kini

  • Roxana Mehran

Medical Centers

  • Duke University Medical Center, Chapel Hill, North Carolina

  • Icahn School Of Medicine, New York, New York, USA

  • Medstar, Washington, DC, USA

  • Humanitas Research Hospital, Rozzano, Italy

  • Christiana Care, Glen Mills, Pennsylvania, USA

  • Ochsner Medical Center, New Orleans, Louisiana, USA

  • Mount Sinai Medical Center, New York, New York, USA

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Cleveland Clinic Cleveland Ohio USA

  • Humanitas University, Milan, , Italy

  • The Lindner Center for Research and Education at the Christ Hospital, Cincinnati, Ohio, USA

Locations

  • United States

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

  • Multi-vessel disease

  • Stroke

Biomarkers

  • Microvessel density

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved